The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study

Volume: 59, Issue: 5, Pages: 995 - 1004
Published: Jan 8, 2021
Abstract
Objectives Midregional pro-adrenomedullin (MR-proADM) is a vasoactive peptide with key roles in reducing vascular hyperpermeability and thereby improving endothelial stability during infection. While MR-proADM is useful for risk stratification in patients with sepsis, clinical data about prediction accuracy in patients with severe acute respiratory syndrome coronavirus 2 disease (COVID-19) is currently missing. Methods We included consecutively...
Paper Details
Title
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
Published Date
Jan 8, 2021
Volume
59
Issue
5
Pages
995 - 1004
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.